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Background: Concerns have been raised regarding growth in advanced diagnostic imaging use. This study evaluated
trends in national outpatient MRI/CT utilization rates during 2000-2009 and factors associated with utilization.
Methods: This retrospective database analysis used data on all respondents in the nationally representative U.S. Medical
Expenditure Panel Survey (MEPS) during 2000-2009. Visits involving advanced diagnostic imaging were identified based
on self-reported use of MRI or CT tests at emergency departments, office-based medical providers, and outpatient
departments. The imaging utilization rate was defined as the number of outpatient visits with MRI/CT per 1,000
person-years. Results were weighted to create nationally representative estimates at the person-year level for each year
and the pooled 10-year period. A multivariate logistic regression was estimated to identify predictors of imaging use.
Results: A total of 319,246 person-years were included in the analysis. MRI/CT utilization rates increased from 64.3 to
109.1 per 1,000 person years from 2000 to 2009, with older persons, females and Medicare enrollees having higher rates
of use. Growth in imaging slowed in recent years; the average annual decline in the imaging growth rate was larger than
that for all outpatient services (4.7% vs. 0.9%). The percentage of respondents with MRI/CT use (6.7% during 2000-2009)
also increased at a slower rate in later years and declined during 2007-2009. The average number of MRI/CT visits among
imaging users was steady at about 1.5 visits during 2000-2009. Age, female gender, White race, HMO participation, and
all payer types (vs. uninsured) were significant predictors of imaging use. Compared to 2005, years 2000-2003
were associated with a significantly lower likelihood of imaging use, while years 2004-2009 were not significantly
associated, suggesting a slow-down in later years.
Conclusions: Growth in advanced imaging utilization appears to have slowed in recent years, a finding of potential
interest to policy-makers and payers.
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It has been well documented that use of diagnostic im-
aging technology grew rapidly in the early 2000s [1-5].
The rate of growth in imaging use was substantial, with
a 70% cumulative increase in utilization between 2000
and 2007 among Medicare beneficiaries, compared to
a less than 40% increase for all physician services [2].
Between 2000 and 2006 annual Medicare spending on
magnetic resonance imaging (MRI), computed tomog-
raphy (CT), and positron emission tomography (PET)* Correspondence: jmenzin@bhei.com
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reproduction in any medium, provided the orscans rose from $3.6 billion to $7.6 billion (approximately
17% per year) [2].
Despite high growth rates observed in the early 2000s,
recently there have been signs that rates of imaging
utilization began to slow around 2005 [6-9]. It has been
shown that the compound annual growth rate of CT use
among Medicare beneficiaries has dropped substantially
when comparing 2000-2006 and 2007-2009 and has
fallen even more drastically for MRI [6,9].
While these results suggest a slowing trend in the
growth of imaging utilization among Medicare benefi-
ciaries, [7-10] there are limited recent data examining
similar trends across all payers. Lee and Levy reportedd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CT and MRI among commercial payers, and Bhargavan
and colleagues evaluated imaging utilization at the na-
tional level, but only included data as recent as 2001
[1,6]. Our study aimed to: (1) evaluate whether the slow-
ing utilization observed in the Medicare population also
occurred among other populations (e.g., patients with
other insurance coverage, different demographic groups),
(2) assess whether the observed trends in utilization con-




This retrospective database analysis used data from the
U.S. Medical Expenditure Panel Survey (MEPS), a con-
tinuous, ongoing dataset of large-scale surveys of families
and individuals, their medical providers, and insurers
across the U.S. that gather data on the frequency of use
and costs of specific health services. Information is col-
lected from a nationally representative sample of the U.S.
civilian noninstitutionalized population using a complex,
multi-stage survey design.
The 10-year MEPS sample (2000-2009) used in this
study includes data on 319,246 person-years. The MEPS
Full Year Consolidated (FYC) Files, Emergency Room (ER)
Visits Files, Office-based Medical Provider Visits Files,
and Outpatient Department Visits Files were used. Free-
standing imaging centers are captured in the Office-
based Medical Provider Visits Files.
The FYC File summarizes all of the person-level vari-
ables in the same year into one file, including demo-
graphics, health insurance, and a person weight which is
used to create national estimates based on the sample
collected in MEPS. Relevant variables in the encounter-
level files (e.g., ER visits) include the visit date and
whether there was imaging use during the visit [11]. All
data files used in these analyses are publicly available for
download on the MEPS website [12].
Patient selection
All MEPS respondents between 2000 and 2009 were
included in the analysis for all years in which they had a
positive person weight. Similar to other published stud-
ies, unique combinations of patient ID and year were
used to identify person-year observations (i.e., the same
person in two consecutive years was treated as two dif-
ferent people) [13,14].
Study measures
Outpatient visits from any of the outpatient files (i.e., emer-
gency department [ED], office-based medical provider, and
outpatient department visits) involving MRI/CT were iden-
tified based on an affirmative answer to: “Did the personhave an MRI or CT during this visit?” As we were unable
to discern the number of imaging procedures the person
had at the visit, the imaging utilization rate was defined as
the number of visits with MRI/CT per 1,000 persons, ra-
ther than the number of procedures per 1,000 persons.
Similarly, the overall outpatient visit rate, used as a refer-
ence point, was defined as the total number of all visits per
1,000 persons. The proportion of respondents who had at
least one outpatient visit with MRI/CT and the proportion
of outpatient visits with MRI/CT were also assessed.
Among those who had at least one visit for an MRI/
CT during a year, the average number of outpatient
visits with an MRI/CT for that year was also evaluated.
The average annual growth rate in imaging utilization
was calculated as the average of the annual growth rates
for all individual years during a given time period [15].
The average annual decrease in the growth rate was cal-
culated as: (annual growth rate in the last year–annual
growth rate in the first year)/number of years.
Data analysis
Descriptive analyses of all study measures were per-
formed. Data from all years were pooled into an overall
study database, and all study measures were analyzed for
each year and for the 10-year period. Results were
weighted to the national level using longitudinal person
weights. These survey weights are provided by MEPS to
adjust for unequal probabilities of selection into the sur-
vey, as well as for survey nonresponse and attrition.
Analyses were stratified by patient demographics, payer
type, and managed care participation.
Each respondent was grouped into one of the following
payer categories: Medicare only, Medicaid only, Private
only, Medicare +Medicaid, Medicare + Private, Other Pub-
lic (TRICARE, State covered, other public), Uninsured, and
Other. MEPS provides information on payer status for
each month; payer type was assigned as the payer of lon-
gest duration during the year. Those who had the same
duration of coverage with multiple insurance types were
classified as having “Other” coverage.
Managed care participation was defined as whether a
person was covered under a managed care plan (public
or private), including plans defined as an HMO, gate-
keeper plans, or plans with a doctor list [16].
Age-and gender-adjusted imaging and outpatient visit
rates were evaluated, in addition to the unadjusted rates,
based on the direct standardization method, using popu-
lation sizes obtained from US Census Bureau, American
Community Survey 2009 [17,18]. Adjusted rates could
not be calculated for stratified analyses by payer type
and managed care participation due to a lack of data by
payer type in the American Community Survey.
A multivariate logistic regression was estimated to iden-
tify factors associated with a higher likelihood of imaging
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managed care participation, payer type, and year (with
2005 as the reference category). We chose 2005 as the
reference year because other studies have indicated
that CT and MRI use were lower during the period
2005-2008, compared to 1998-2005 [6,8]. Three sup-
plementary logistic regressions with alternative speci-
fications for the year variable were estimated to test
whether growth in imaging was slower after 2005 (Details
regarding the methods and results of these supplementary
regressions are provided in the Appendix). Statistical sig-
nificance was defined as a P-value less than 0.05. SAS soft-




Approximately 25% of the sample was less than 18 years
old, 38% between 18 and 44, 25% between 45 and 64
and 12% aged 65 and older over the entire 10-year
period. Males comprised 49% of the population and over
80% were from urban areas. Demographics were gener-
ally similar in each year over the 10-year period. The
gender distribution remained constant, as did the age
distribution, with a slight trend of increasing proportions
falling into the older age groups. Nearly two-thirds of
the population was White, with a slightly lower preva-
lence in later years (71% in 2000 and 65% in 2009).
The distribution of the population among payer types
remained fairly steady over the 10-year period. There
was a small decrease in the percent of people with pri-
vate insurance (59.2% in 2000 and 52.4% in 2009), which
corresponded with increases in the proportion of pa-
tients with Medicaid (7.4% in 2000 and 11.4% in 2009)
and without health insurance (16.8% in 2000 and 17.8%
in 2009). There was also an increase in the percent with
managed care insurance over the 10-year period (47.4%
in 2000 vs. 55.4% in 2009).
Imaging utilization rates
Overall, MRI/CT utilization rates increased from 64.3 to
119.6 per 1,000 persons from year 2000 to 2008 and
then declined to 109.1 per 1,000 persons in 2009.
Utilization rates increased at a rate of just under 15% in
the first five years of the time period and then at an an-
nual average growth rate of almost 0% for 2005-2009
(Table 1, Figure 1). This trend was observed across al-
most all patient groups (i.e., defined by age, gender, race,
and region) and payor types. Age-and gender-adjusted
rates (results not shown) were similar to unadjusted
rates, reflecting the minimal changes in patient demo-
graphics over the 10-year window.
Older people tended to have higher rates of im-
aging use, with average MRI/CT utilization rates ofapproximately 24, 72, 159, and 240 per 1,000 persons
for ages <18, 18-44, 45-54 and 65+ years, respectively.
Females had higher rates of imaging use than males
(115 vs. 90 per 1,000 persons during 2000-2009). The
uninsured and those with only Medicaid coverage had
similar rates of imaging use that were the lowest rates
observed over 2000-2009 across all payer types (52 per
1,000 persons for the uninsured and 63 per 1,000 per-
sons for those with Medicaid only). In contrast, those
with any Medicare coverage had the highest rates of
utilization (ranging from 227 to 258 per 1,000 persons
for these payer groups over the 10-year period). In the
earlier years (2000-2005), imaging utilization among those
with non-managed care insurance was consistently higher
than among those with a managed care plan. How-
ever, in the most recent years (2006-2009), the utilization
rates by managed care participation appeared to converge
(Figure 2).
The average decrease in the annual growth rate for
MRI/CT use between 2000 and 2009 (4.7%) was larger
than the average decrease in the general outpatient visit
growth rate (0.9%). In addition, the percent of outpatient
visits involving an MRI/CT increased from 2000 (1.3%)
to 2008 (2.1%), then decreased in 2009 to 1.9%. The
average decrease in the annual growth rate for the per-
cent of outpatient visits involving MRI/CT (3.5%) was
also larger than the average decrease in the general out-
patient visit growth rate. These results suggest a larger
slowdown in MRI/CT growth than in overall outpatient
services growth.
The percentage of patients who had at least one visit
involving MRI/CT use increased at a slower rate in more
recent years and decreased between 2007 and 2009. The
percentage of patients with at least one visit with im-
aging use was highest among those aged 65+ years,
at approximately 15.0% over 2000-2009. Females were
more likely than males to use MRI/CT: 7.5% vs. 5.8%
respectively over the 10-year period. The uninsured and
people with Medicaid were least likely to use MRI/CT
services (3.4% and 3.9% during 2000-2009, respectively),
while those with any Medicare coverage were most
likely, ranging from 13.1% to 16.3%. Managed care plan
holders were slightly less likely to receive an imaging
test (6.6% vs. 6.9% during 2000-2009), compared to
non-managed care plan holders. The average number
of visits with an MRI/CT performed, among those people
who had at least 1 imaging visit, was steady (ranging
from 1.4 to 1.6) during the 2000-2009 period for all
stratifications.
Predictors of imaging utilization
Results from a multivariate logistic regression indicated
that increasing age, female gender, White race, living in an
urban area, having managed care insurance, and having
Table 1 Imaging utilization rate (number of outpatient visits with MRI/CT per 1,000 persons), by year and
patient characteristics
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2000-2009*
Unweighted N 23,839 32,122 37,418 32,681 32,737 32,320 32,577 29,370 31,262 34,920 319,246
Imaging utilization rate 64.3 85.9 92.3 107.2 109.6 112.6 107.4 116.8 119.6 109.1 102.9
Age
<18 14.3 20.4 24.2 29.3 20.3 27.1 21.4 24.1 27.4 26.8 23.6
18-44 44.5 74.7 67.1 62.9 87.0 81.1 80.5 72.7 73.4 74.8 71.9
45-64 97.5 121.9 141.3 186.0 161.5 170.6 164.1 171.8 185.8 172.5 159.1
65+ 160.9 182.6 219.3 244.0 253.8 261.4 241.4 309.3 282.8 234.3 240.4
Gender
Male 54.7 78.1 80.3 92.2 93.5 98.6 92.6 106.3 98.8 99.4 89.8
Female 73.5 93.3 103.8 121.6 125.0 126.1 121.7 126.9 139.6 118.6 115.4
Race/ethnicity
White 73.5 95.9 108.5 126.3 128.6 135.3 127.3 137.9 146.6 133.7 121.4
Non-white 41.7 62.9 58.3 67.3 71.2 67.8 69.1 76.7 68.8 63.7 65.3
Census region
Northeast 72.3 109.2 97.1 108.7 129.3 120.7 128.8 140.1 135.3 112.7 115.6
South 64.6 81.5 93.1 114.6 112.0 116.4 109.9 111.2 102.2 110.3 102.1
Midwest 57.3 88.1 96.2 95.0 109.7 119.9 105.2 118.6 131.4 108.7 103.2
West 56.2 66.5 83.0 102.2 87.7 91.8 86.5 101.6 117.3 104.6 90.3
Rural/urban residence
MSA 61.0 87.1 89.0 106.3 106.7 111.9 105.3 116.0 118.7 110.2 101.8
Non-MSA 68.9 74.5 106.4 105.8 120.6 113.7 114.9 114.7 114.5 102.7 103.4
Payer type
Medicare 131.4 195.2 187.0 238.7 241.3 255.6 261.8 276.0 303.8 223.1 234.2
Medicaid 32.2 62.1 65.8 60.3 58.3 78.9 67.8 58.1 69.1 62.4 62.5
Private 52.8 78.0 84.0 91.2 96.7 97.8 95.1 98.7 105.4 96.9 89.6
Medicare + Medicaid 183.6 124.4 248.5 194.9 269.5 227.5 172.0 240.9 219.0 357.5 226.8
Medicare + Private 180.5 188.0 237.9 253.2 265.0 295.9 250.6 364.0 300.6 253.3 257.8
Other public** 243.0 235.1 78.4 100.5 98.2 122.7 104.7 133.1 123.4 149.3 131.4
Uninsured 32.9 37.2 30.8 74.3 61.1 54.8 58.1 60.6 48.9 56.2 51.8
Other 91.2 96.8 134.4 175.1 165.5 160.2 165.1 141.0 205.9 164.3 152.5
Managed care status
Managed care 59.0 80.2 86.4 97.3 103.1 107.9 108.3 118.6 113.4 114.9 99.9
Non-managed care 69.1 93.8 100.7 121.0 118.5 119.0 106.2 114.4 127.2 102.0 106.8
Source: Medical Expenditure Panel Survey 2000-2009.
MSA: Metropolitan Statistical Area.
Note: Outpatient visits include outpatient, office-based, and ER visits.
Note: Weighted results are reported to reflect US noninstitutionalized population.
Note: 2000-2009 results represent weighted, pooled data from each year from 2000-2009.
*2000-2009 estimates were calculated on a pooled sample of imaging visits over all data years.
**Other public includes Tricare, State covered insurance and other public insurance.
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having an outpatient visit involving MRI/CT (Table 2).
Compared to 2005, years 2000-2003 were associated with
a significantly lower likelihood of having MRI/CT
visits, while years 2004 and 2006 through 2009 werenot significant predictors of use, suggesting a slow-down
in advanced imaging utilization in later years.
In three supplementary logistic regressions involving
alternative specifications for the year variable, we con-
firmed that imaging rates increased significantly in years
Figure 1 Imaging utilization rate, by year.
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period (see Appendix). A schematic illustration of these
results is shown in Figure 3.
Discussion
Summary & implications
This study evaluated nationally representative trends
in outpatient imaging utilization over the last decade
stratified by patient age, gender, region of residence,
and insurance type, and identified key factors associated
with imaging utilization. Results suggested an averageFigure 2 Imaging utilization rate, by year and managed care participgrowth rate in imaging utilization of 15% over the first
five years of the decade (2000-2004), then leveling off
to an approximately 0% growth rate between 2005-
2009. After controlling for patient age, female gender,
race, and type of insurance coverage, the years 2000-
2003 were statistically significantly associated with higher
likelihood of imaging use vs. the year 2005, while years
2004 and 2006-2009 were not significant predictors
of imaging utilization, therefore confirming the un-
adjusted results of a slowdown in imaging use in recent
years.ation.
Table 2 Factors associated with likelihood of having an
outpatient MRI/CT visit
Covariate OR estimate 95% confidence
limits
Managed care vs. non-managed care 1.066 1.015 1.120
Payer type (vs. uninsured)
Medicare 2.749 2.437 3.102
Medicaid 1.987 1.799 2.195
Private 1.619 1.505 1.741
Medicare + Medicaid 3.076 2.708 3.493
Medicare + Private 3.027 2.678 3.422
Other public* 2.194 1.818 2.647
Other 2.375 2.153 2.620
Year (vs. 2005)
2000 0.579 0.523 0.642
2001 0.737 0.678 0.801
2002 0.865 0.798 0.937
2003 0.890 0.828 0.956
2004 0.950 0.882 1.025
2006 0.987 0.915 1.064
2007 1.043 0.971 1.120
2008 1.013 0.936 1.097
2009 0.969 0.894 1.051
Age (vs. <18 years)
18-44 years 2.954 2.746 3.178
45-64 years 5.514 5.126 5.931
65+ years 5.016 4.469 5.630
Male (vs. female) 0.820 0.790 0.850
White (vs. non-white) 1.598 1.526 1.674
Census region (vs. Northeast)
South 0.985 0.924 1.050
Midwest 0.970 0.904 1.041
West 0.843 0.780 0.911
Urban (vs. rural) 1.056 1.000 1.114
Source: Medical Expenditure Panel Survey 2000-2009.
Note: Outpatient visits include outpatient, office-based, and ER visits.
*Other public includes Tricare, State covered insurance and other public insurance.
Note: Bold indicates statistical significance (P-Value < 0.05).
Note: Regression is based on weighted results.
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has slowed not only among Medicare beneficiaries, but
also among those with other types of insurance. This
slowdown outpaced declines in the growth rate for out-
patient services overall, indicating that the stabilizing
trend of imaging use can be attributed to reasons other
than just declines in growth in all-cause outpatient visits
per year. These findings suggest that the greater observed
slowdown in imaging use vs. outpatient visits overall may
not merely be due to recent economic trends. Given thatpatterns of imaging use were similar among patients with
Medicaid coverage and patients without any insurance
coverage, and given the expectation that over half of the
currently uninsured will qualify for Medicaid under the
2010 Patient Protection and Affordable Care Act, our find-
ings suggest that health reform may not cause a drastic in-
crease in advanced imaging utilization as the number of
insured increases [19].
Other potential reasons for this observed slowdown in
imaging use are suggested by Levin et al. and Sharpe et al.
in their respective analyses of trends of CT and MRI use
[20,21]. First, there is a greater awareness among both
physicians and patients of radiation concerns associated
with imaging use. Radiologists have been working to edu-
cate healthcare professionals and improve patient aware-
ness concerning radiation exposure through educational
campaigns, such as the introduction of the Image Wisely
campaign by the American College of Radiology (ACR)
and the Radiological Society of North America (RSNA) in
2010 [22]. Second, cost concerns may cause physicians to
pay more attention to the ACR appropriateness criteria
for imaging use [23].
Comparison to literature
The rates of advanced diagnostic imaging utilization ob-
served in this study among Medicare patients are lower
than those reported in studies using the Medicare Phys-
ician Supplier files. Levin and colleagues report a rate of
outpatient CT and MRI use of 437 per 1,000 Medicare
beneficiaries in 2008, compared to our results ranging
from 219-304 outpatient visits with a MRI/CT per person
among people with Medicare only, Medicare + Private in-
surance or Medicare + Medicaid in 2008 [8]. This discrep-
ancy was also observed in Bhargavan and colleagues’ 2005
study, which examined both the Medicare Physician Sup-
plier files and MEPS data to assess utilization. They report
an ambulatory MR/CT utilization rate of 151 procedures
per 1,000 person 65 years or older using 1999 MEPS data
and a rate of 341 procedures per 1,000 Medicare benefi-
ciaries in 2001 using the Physician Supplier files [1]. These
differences may be due to the fact that analyses of admin-
istrative claims from the Medicare Physician Supplier files
are based on Current Procedural Terminology (CPT)
codes for imaging procedures, whereas analyses using
MEPS are based on self-report. However, MEPS adminis-
trators do make an attempt to verify respondent reported
information. Additionally, due to the nature of the ques-
tion “Did the person have an MRI or CT during this
visit?”, we cannot capture multiple procedures occurring
during the same visit, which is why we report utilization
rates as ‘number of visits with MRI/CT’, rather than MRI/
CT procedures.
While the absolute utilization rates reported here may
differ from other studies using administrative claims, the
Figure 3 Multivariate logistic regression results of odds of an outpatient MRI/CT visit during 2000-2004 and 2005-2009 versus
unadjusted overall number of MRI/CT visits per 1,000 persons.
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over the 10-year period; therefore, our observations re-
lated to the trend of decelerating growth in advanced
diagnostic imaging use are consistent with other studies
among Medicare populations. Similar to our findings, a
2012 study of outpatient (i.e., office and hospital out-
patient department) imaging use among Medicare bene-
ficiaries observed a distinct flattening of trend lines in
CT and MRI use in outpatient settings between 2005
and 2006 [6,9]. This study reported the compound an-
nual growth rate for CT use fell from 17.5% for office
visits and 8.6% for hospital outpatient departments be-
tween 2000 and 2006 to 2.1% and 0.5%, respectively, be-
tween 2007 and 2009. Similarly, MRI utilization rates fell
from 14.9% and 11.3% for office and hospital outpatient
departments, between 2000 and 2006 to −1.1% and 1.0%
between 2007 and 2009 [9]. Other analyses of Medicare
Part B data have reported that the rate of growth for ad-
vanced imaging technologies including CT, MRI, and
PET had fallen between 2006-2008 to as low as 1-2%
[7,24]. These trends are in line with our results for out-
patient MRI/CT utilization rates among those with
Medicare coverage, where the average annual growth
rate was 11.1% during 2000-2005 and 3.7% during 2005-
2008 (−0.7% over 2005-2009). Our results showed that
the annual growth rate in national outpatient MRI/CT
utilization followed the same pattern as observed in the
Medicare population: 12.4% over 2000-2005 falling to
2.2% over 2005-2008 (to −0.6% for 2005-2009).
Previous studies have reported inconsistent findings
regarding the relationship between managed care mem-
bership and use of imaging services [4,25,26]. In ananalysis of electronic medical record data from HMO
enrollees in six integrated health systems, results sug-
gested that both CT and MRI use increased between 1996
and 2010 [26]. Conversely, results from a nationwide “cen-
sus” of MRI sites in 1993, 1997, and 1999 suggested that
metropolitan statistical areas with a higher HMO market
share had statistically significantly lower adoption and use
of MRI scanners compared to areas with lower HMO
prevalence [16]. Our study suggested, in descriptive ana-
lyses, that patients enrolled in managed care plans were
slightly less likely (6.6% vs. 6.9%) to utilize MRI/CT ser-
vices, but the utilization rate appeared to converge in later
years. Furthermore, in multivariate regression, patients in
managed care plans were found to be significantly more
likely to use imaging services after controlling for other
characteristics (payer type, year, age, gender, race, region
and urban/rural status). The uncertainty surrounding
the relationship between managed care plan member-
ship and imaging use, and a lack of published data on this
potential association, raise important questions about
whether financial incentives play a role in imaging use.
This relationship merits further research given the Federal
government’s historical promotion of managed care and
reduced imaging reimbursement as a means to reduce
costs [27-29].
In contrast to our findings that females have a signifi-
cantly higher odds of MRI/CT use versus males, results
from a prior retrospective study of determinants of im-
aging utilization in primary care found that women did
not have a statistically significant greater odds of imaging
use, [30]. However, our results are not directly comparable
to those of Sistrom et al. as their study grouped several
Table 3 Multivariate logistic regression model predicting
the likelihood of having an outpatient MRI/CT visit using
2000-2009 data
Covariate Parameter estimate P-Value
Managed care vs. non-managed care 0.068 0.007




Medicare + Medicaid 1.122 <.0001
Medicare + Private 1.106 <.0001
Other public* 0.787 <.0001
Other 0.865 <.0001
Year**
Year A 0.114 <.0001
Year B −0.115 <.0001
Age (vs. <18 years)
18-44 years 1.083 <.0001
45-64 years 1.708 <.0001
65+ years 1.614 <.0001
Male (vs. female) −0.199 <.0001
White (vs. non-white) 0.468 <.0001




Urban (vs. rural) 0.053 0.054
Source: Medical Expenditure Panel Survey 2000-2009.
Note: Outpatient visits include outpatient, office-based, and ER visits.
Note: Bold indicates statistical significance (P-Value < 0.05).
Note: Regression is based on weighted results.
*Other public includes Tricare, State covered insurance and other public insurance.
**The parameter estimate for Year A represents the best fit slope for 2000-2004
after adjusting for other factors. The sum of parameter estimates for Year A and
Year B (−0.0002, P-value 0.97) represent the best fit slope for 2005-2009. Year A
and Year B were coded as follows:
2000: Year A (1); Year B (0).
2001: Year A (2); Year B (0).
2002: Year A (3); Year B (0).
2003: Year A (4); Year B (0).
2004: Year A (5); Year B (0).
2005: Year A (6); Year B (1).
2006: Year A (7); Year B (2).
2007: Year A (8); Year B (3).
2008: Year A (9); Year B (4).
2009: Year A (10); Year B (5).
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MRI, CT, nuclear medicine, positron emission tomography
(PET), x-ray, and ultrasound. Unadjusted results from their
analyses do show a numerically higher rate of imaging
visits among females (58% of all visits). One possible rea-
son for the significance observed in our study may be the
greater utilization of medical care services in general
among females. According to a recent estimate by the
Agency for Healthcare Research and Quality (AHRQ),
men were 24% less likely than females to visit a doctor
within the past year [31].
Limitations
As this study is a retrospective analysis of household
survey data, it is subject to limitations of the accuracy of
respondent recall and the potential for reporting bias. In
addition, imaging use in the inpatient setting was not
captured in this analysis, and therefore these results may
not be generalizable to imaging use outside of the out-
patient setting.
This study only analyzed outpatient visits for MRI/CT,
excluding inpatient imaging use, similar to approaches
in prior retrospective analyses of imaging use [1,8,9].
Therefore, the findings presented in the current study
may not be generalizable to inpatient settings. However,
results from a recent analysis of Medicare data suggest
that rates of CT use declined between 2009 and 2010 in
both the inpatient and outpatient settings [20]. Add-
itionally, this analysis did not report trends in MRI/CT
use in the ED vs. other outpatient visits separately. Re-
cent literature has suggested that rates of CT use in the
ED are rose dramatically between the mid-1990s and
2007 [32-34]. One analysis of National Hospital Ambula-
tory Medical Care Survey (NHAMCS) showed a 4.9 fold
increase in the percentage of all ER visits with CT use
between 1995 and 2007, [34] with this finding confirmed
in a similar study of NHAMCS data over 1996 to 2007
[32]. Future analysis of trends in ED-specific imaging are
warranted, particularly to examine whether there is evi-
dence of a slowdown in CT use post-2007, and to exam-
ine MRI/CT use jointly.
Another limitation of these analyses is the documented
under-reporting of ED visits in MEPS data. In a com-
parison of the total number of ED visits reported in
the National Hospital Ambulatory Medical Care Survey
(NHAMCS) versus MEPS data, results showed a total of
130 million ED visits in NHAMCS versus 49 million in
MEPS [35]. Potential reasons cited for the under-counting
of ED encounters in MEPS are the undersampling of pa-
tients admitted to an inpatient setting from the ED, the ex-
clusion of institutionalized patients, and underreporting of
patients with Medicaid coverage [35].
Finally there seemed to be an anomaly in our results
for 2006 that did not follow the general observed trendin the imaging utilization rate (number of outpatient visits
with MRI/CT per 1,000 person). Overall, the imaging
utilization rate declined slightly in 2006 and then increased
in 2007 and 2008, but then declined again in 2009. In the
Medicare-only population, the imaging utilization rate in-
creased steadily from year 2000 to year 2008, without a
decline in year 2006, which was consistent with other pub-
lished studies among Medicare beneficiaries [7-9].
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These results provide valuable insights into how patterns
of outpatient advanced imaging use have changed over
time. This more comprehensive understanding of recent
trends and patterns in imaging utilization can inform
policy makers and payers as they develop future imaging-
related policies.
Appendix: supplementary regressions
Three supplementary logistic regressions including the
same predictors as the original regression and alternative
specifications for the year variable were estimated to test
whether growth in imaging was slower after 2005.
The first supplementary regression (shown in Table 3),
included two continuous year variables, one with values
1 through 10 for years 2000-2009 and the other with
values 1 through 5 for years 2005-2009 (with the value
zero for other years). For years 2000-2004, the estimated
slope of the best fit line showing the influence of year onTable 4 Multivariate logistic regression model predicting
the likelihood of having an outpatient MRI/CT visit using
2005-2009 data
Covariate Parameter estimate P-Value
Managed care vs. non-managed care 0.0813 0.0075




Medicare + Medicaid 1.0667 <.0001
Medicare + Private 1.1154 <.0001
Other public* 0.7998 <.0001
Other 0.8215 <.0001
Year** −0.00434 0.6466
Age (vs. <18 years)
18-44 years 1.0995 <.0001
45-64 years 1.7388 <.0001
65+ years 1.6151 <.0001
Male (vs. female) −0.2048 <.0001
White (vs. non-white) 0.4462 <.0001




Urban (vs. rural) 0.089 0.032
Source: Medical Expenditure Panel Survey 2005-2009.
Note: Outpatient visits include outpatient, office-based, and ER visits.
Note: Bold indicates statistical significance (P-Value < 0.05).
Note: Regression is based on weighted results.
*Other public includes Tricare, State covered insurance and other public insurance.
**Year was coded as follows: year 2005 = 1, 2006 = 2, 2007 = 3,
2008 = 4, 2009 = 5.the likelihood of imaging use is based on the coefficient
for the first year variable, while the slope estimate for
2005-2009 is the combination of the two year variable
coefficients. Results suggest that imaging rates increased
significantly in the early years and then stabilized after
2005 (since the sum of the coefficients is close to zero).
The significance of the 2005-2009 year variable suggests
that growth in imaging was significantly different for the
two periods.
In the second regression including data from only
2005-2009 and one continuous year variable, the year
variable was not significant, suggesting no growth in im-
aging during this period (Table 4). The third regression
including data from 2000-2004 and one continuous year
variable produced a coefficient very similar to that esti-
mated for years 2000-2004 in the first regression, confirm-
ing significant growth during the early years (Table 5).
A schematic illustration of these results is shown in
Figure 3 of the full text.Table 5 Multivariate logistic regression model predicting
the likelihood of having an outpatient MRI/CT visit using
2000-2004 data
Covariate Parameter estimate P-Value
Managed care vs. non-managed care 0.044 0.237




Medicare + Medicaid 1.194 <.0001
Medicare + Private 1.093 <.0001
Other public* 0.761 <.0001
Other 0.924 <.0001
Year** 0.113 <.0001
Age (vs. <18 years)
18-44 years 1.064 <.0001
45-64 years 1.669 <.0001
65+ years 1.616 <.0001
Male (vs. female) −0.191 <.0001
White (vs. non-white) 0.500 <.0001




Urban (vs. rural) 0.014 0.661
Source: Medical Expenditure Panel Survey 2000-2004.
Note: Outpatient visits include outpatient, office-based, and ER visits.
Note: Bold indicates statistical significance (P-Value < 0.05).
Note: Regression is based on weighted results.
*Other public includes Tricare, State covered insurance and other public insurance.
**Year was coded as follows: year 2000 = 1, 2001 = 2, 2002 = 3,
2003 = 4, 2004 = 5.
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